双层双能CT对肾脏病变的表征:虚拟平扫与真实平扫图像的比较
该回顾性研究纳入110例患者219个肾脏病变,比较双层双能CT虚拟平扫与真实平扫图像鉴别囊性与实性病变的能力。实性病变增强≥20 HU的检出率两者均为90.9%,但虚拟平扫低估单纯囊性和高密度囊肿的衰减,导致部分囊肿出现假阳性增强。结论不支持用虚拟平扫替代真实平扫进行肾脏病变表征。
要点
- 实性病变增强≥20 HU的检出率虚拟平扫与真实平扫均为90.9%。
- 虚拟平扫在单纯囊肿和高密度囊肿中可误判为增强≥20 HU,分别有12个和9个。
- 虚拟平扫低估单纯囊肿和高密度囊肿的衰减,实性病变衰减轻度高于真实平扫。
核心结论
- 虚拟平扫可可靠检出实性病变的增强,但低估单纯囊肿和高密度囊肿的衰减,导致此类病变出现假阳性增强;研究结果不支持用虚拟平扫替代真实平扫进行双层双能CT肾脏病变表征。
研究设计与样本
- 回顾性研究,纳入2018年7月至2022年2月行肾脏肿块方案双层双能CT的110例患者(平均年龄64.3±11.8岁;46例女性,64例男性),重建真实平扫、虚拟平扫和肾实质期图像;实性病变由组织病理学或MRI诊断,囊肿由综合MRI、超声及双层双能CT真实平扫和肾实质期图像的综合标准诊断;由一名放射科医生测量所有图像集的病变衰减。
关键影像表现/征象
- 实性病变真实平扫衰减33.4±7.1 HU,虚拟平扫35.4±8.6 HU(p=.002)。
- 单纯囊肿真实平扫衰减10.8±5.6 HU,虚拟平扫7.1±8.1 HU(p<.001)。
- 高密度囊肿真实平扫衰减56.3±21.0 HU,虚拟平扫47.6±16.3 HU(p<.001)。
- 分隔囊肿真实平扫衰减13.6±8.1 HU,虚拟平扫14.0±6.8 HU(p=.79)。
诊断标准与关键数值
- 以增强≥20 HU提示存在实性肿块;真实平扫与虚拟平扫增强≥20 HU的频率在实性病变均为90.9%,单纯囊肿分别为0.0%和9.1%,分隔囊肿分别为15.0%和10.0%,高密度囊肿分别为11.8%和38.2%。
- 所有实性病变在真实平扫与虚拟平扫间增强≥20 HU的判定一致;12个单纯囊肿和9个高密度囊肿在虚拟平扫但非真实平扫出现增强≥20 HU。
临床应用与阅片要点
- 虚拟平扫可可靠检出实性病变的增强,但单纯囊肿和高密度囊肿在虚拟平扫上可能出现假阳性增强。
- 研究结果不支持用虚拟平扫替代真实平扫进行双层双能CT肾脏病变表征。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Prior studies have provided mixed results for the ability to replace true unenhanced (TUE) images with virtual unenhanced (VUE) images when characterizing renal lesions by dual-energy CT (DECT). Detector-based dual-layer DECT (dlDECT) systems may optimize performance of VUE images for this purpose. OBJECTIVE. The purpose of this article was to compare dual-phase dlDECT examinations evaluated using VUE and TUE images in differentiating cystic and solid renal masses. METHODS. This retrospective study included 110 patients (mean age, 64.3 ± 11.8 years; 46 women, 64 men) who underwent renal-mass protocol dlDECT between July 2018 and February 2022. TUE, VUE, and nephrographic phase image sets were reconstructed. Lesions were diagnosed as solid masses by histopathology or MRI. Lesions were diagnosed as cysts by composite criteria reflecting findings from MRI, ultrasound, and the TUE and nephrographic phase images of the dlDECT examinations. One radiologist measured lesions' attenuation on all dlDECT image sets. Lesion characterization was compared between use of VUE and TUE images, including when considering enhancement of 20 HU or greater to indicate presence of a solid mass. RESULTS. The analysis included 219 lesions (33 solid masses; 186 cysts [132 simple, 20 septate, 34 hyperattenuating]). TUE and VUE attenuation were significantly different for solid masses (33.4 ± 7.1 HU vs 35.4 ± 8.6 HU, p = .002), simple cysts (10.8 ± 5.6 HU vs 7.1 ± 8.1 HU, p < .001), and hyperattenuating cysts (56.3 ± 21.0 HU vs 47.6 ± 16.3 HU, p < .001), but not septate cysts (13.6 ± 8.1 HU vs 14.0 ± 6.8 HU, p = .79). Frequency of enhancement 20 HU or greater when using TUE and VUE images was 90.9% and 90.9% in solid masses, 0.0% and 9.1% in simple cysts, 15.0% and 10.0% in septate cysts, and 11.8% and 38.2% in hyperattenuating cysts. All solid lesions were concordant in terms of enhancement 20 HU or greater when using TUE and VUE images. Twelve simple cysts and nine hyperattenuating cysts showed enhancement of 20 HU or greater when using VUE but not TUE images. CONCLUSION. Use of VUE images reliably detected enhancement in solid masses. However, VUE images underestimated attenuation of simple and hyperattenuating cysts, leading to false-positive findings of enhancement by such lesions. CLINICAL IMPACT. The findings do not support replacement of TUE acquisitions with VUE images when characterizing renal lesions by dlDECT.
引用
- Cao, Lennartz, Pisuchpen, et al. Renal Lesion Characterization by Dual-Layer Dual-Energy CT: Comparison of Virtual and True Unenhanced Images. AJR Am J Roentgenol. 2022. PMID: 35441533. doi:10.2214/AJR.21.27272
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。